Kalevi Pulkkanen

1.3k citations
20 papers · 967 indexed · 1 hit paper · h-index 10
Topics
Prostate Cancer Treatment and Research (10 papers)Radiopharmaceutical Chemistry and Applications (9 papers)Medical Imaging Techniques and Applications (5 papers)
Partner nations
FinlandSwedenNorway

In The Last Decade

Kalevi Pulkkanen

19 papers receiving 933 citations

Hit Papers

Inhibition of lymphangiogenesis with resulting lymphedema...20012026200920172001200400600

Peers

Kalevi Pulkkanen
Comparison fields: 5 of 85
  • Oncology 606
  • Molecular Biology 548
  • Surgery 181
  • Physiology 173
  • Genetics 137
Replace Young-Kwon Hong with:
Young-Kwon Hong United States
Maria Wirzenius Finland
Haruka Wada Japan
Bradley McColl Australia
Maria H. Ulvmar Sweden
Mario Grisanti United States
Ailsa J. Christiansen Switzerland
Unja Martin United States
Takashi Shimoaka Japan
Michaël Chopin Australia
Kalevi Pulkkanen relative to Young-Kwon Hong United States Young-Kwon Hong's profile →
Citations per field
00.5×2.9×
Young-Kwon Hong · 1×
Citations per year

Countries citing papers authored by Kalevi Pulkkanen

Since Specialization
Citations

This map shows the geographic impact of Kalevi Pulkkanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalevi Pulkkanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalevi Pulkkanen more than expected).

Fields of papers citing papers by Kalevi Pulkkanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalevi Pulkkanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalevi Pulkkanen. The network helps show where Kalevi Pulkkanen may publish in the future.

Co-authorship network of co-authors of Kalevi Pulkkanen

This figure shows the co-authorship network connecting the top 25 collaborators of Kalevi Pulkkanen. A scholar is included among the top collaborators of Kalevi Pulkkanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalevi Pulkkanen. Kalevi Pulkkanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 3
3 16
4 1
5 21
6 1
7 1
8 1
9 1
10 9
11 2
12 148
13 3
14 22
15 22
16 0
17 20
18 23
19
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3breakdown →
612
20 53

About Kalevi Pulkkanen

Kalevi Pulkkanen is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Biotechnology, having authored 20 papers that have together received 967 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Medical Imaging Techniques and Applications (5 papers). The work is most often cited by research in Oncology (606 citations), Molecular Biology (548 citations) and Physiology (173 citations). Kalevi Pulkkanen has collaborated with scholars based in Finland, Sweden and Norway. Frequent co-authors include Seppo Ylä‐Herttuala, Risto A. Kauppinen, Mikko I. Kettunen, Taija Mäkinen, Kari Alitalo, David G. Jackson, Hajime Kubo, Tanja Veikkola, Shin‐Ichi Nishikawa and Lotta Jussila. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026